Table 3.
Escherichia coli antibiotic resistance profile to a panel of antibiotics, proportion of isolates resistant to any antibiotic, and proportion of multidrug-resistant isolates, where multidrug resistance was defined as resistance to three or more classes of antibiotics
| Antibiotic | Susceptible, % (N) | Intermediate, % (N) | Resistant, % (N) | % Resistant (95% CI) |
|---|---|---|---|---|
| Amoxicillin–clavulanic acid | 90.6% (106) | 6.0% (7) | 3.4% (4) | (0.94, 8.5) |
| Ampicillin | 48.7% (57) | 23.1% (27) | 28.2% (33) | (20.3, 37.3) |
| Azithromycin | 93.2% (109) | – | 6.8% (8) | (3.0, 13.0) |
| Cefotaxime | 94.9% (111) | 1.7% (2) | 3.4% (4) | (0.94, 8.5) |
| Cefoxitin | 96.8% (30) | – | 3.2% (1) | (0.08, 16.7) |
| Chloramphenicol | 88.9% (104) | 0.0% (0) | 11.1% (13) | (6.1, 18.3) |
| Ciprofloxacin | 90.6% (106) | 5.1% (6) | 4.3% (5) | (1.4, 9.7) |
| Gentamicin | 97.4% (114) | – | 2.6% (3) | (0.53, 7.3) |
| Nalidixic acid | 85.5% (100) | 5.1% (6) | 9.4% (11) | (4.8, 16.2) |
| Nitrofurantoin | 94.9% (111) | 3.4% (4) | 1.7% (2) | (0.21, 6.0) |
| Trimethoprim–sulfamethoxazole | 81.2% (95) | 0.9% (1) | 17.9% (21) | (11.5, 26.1) |
| Tetracycline | 67.5% (79) | – | 32.5% (38) | (24.1, 41.8) |
| Any antibiotic | – | – | 48.7% (57) | (39.4, 58.1) |
| Multidrug resistance | – | – | 19.7% (23) | (12.9, 28.0) |